On Oct. 8, 2014, Ohio State University, Cardinal Health and State of Ohio Third Frontier Commission announced completion of a five-year-long project to create a new, $13 million molecular imaging pharmaceuticals center that aimed to shape the future of the medical diagnostic industry.

The state-of-the-art, 27,000-square-foot facility was named the Translational Research Center for Molecular Imaging Pharmaceuticals at the Wright Center of Innovation in Biomedical Imaging.